ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PATRICIA SALVATO M.D.

Internal Medicine

28,382

$4.45M

908
256 are 65+

29%
patients receiving schedule two controlled substances

Avg: 1%

45%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$157
Average prescription price

Avg: $67

RICHARD LE M.D.

Internal Medicine

19,189

$2.62M

715
559 are 65+

N/A

27%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 27%

$137
Average prescription price

Avg: $67

CARLOS CASAS M.D.

Internal Medicine

32,277

$2.25M

842
689 are 65+

N/A

17%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $67

RUBEN DE LOS SANTOS MD PA

Internal Medicine

32,391

$2.08M

1041
835 are 65+

N/A

17%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $67

JACQUELINE CARRUTHERS M.D.

Internal Medicine

24,550

$1.78M

819
540 are 65+

N/A

22%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $67

YONG CHANG MD

Internal Medicine

19,585

$1.67M

872
716 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$85
Average prescription price

Avg: $67

JAMES RACE

Internal Medicine

27,957

$1.55M

1066
719 are 65+

N/A

30%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $67

RAMON PINEDA M.D.

Internal Medicine

35,087

$1.53M

1165
944 are 65+

N/A

15%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$44
Average prescription price

Avg: $67

ALBERT DALLEY MD

Internal Medicine

29,527

$1.51M

1009
812 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $67

NORMA RIVERA-OPIO M.D.

Internal Medicine

21,044

$1.47M

988
773 are 65+

N/A

16%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $67

JORGE GUEVARA MD

Internal Medicine

20,542

$1.35M

863
689 are 65+

N/A

17%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 27%

$66
Average prescription price

Avg: $67

E. HUDMAN M.D.

Internal Medicine

19,863

$1.3M

793
582 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$65
Average prescription price

Avg: $67

ROBERT MARQUINEZ M.D.

Internal Medicine

12,352

$1.27M

627
446 are 65+

N/A

4%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$103
Average prescription price

Avg: $67

LENIN PINNAMANENI M.D.

Internal Medicine

26,177

$1.23M

743
541 are 65+

N/A

38%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$47
Average prescription price

Avg: $67

ANGEL PEREZ MD

Internal Medicine

21,750

$1.14M

712
502 are 65+

N/A

30%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

GARY BUTKA M.D.

Internal Medicine

16,733

$1.14M

649
504 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$68
Average prescription price

Avg: $67

MINH LE M.D.

Internal Medicine

10,086

$1.12M

429
358 are 65+

N/A

10%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

43%
prescriptions for brand name drugs

Avg: 27%

$111
Average prescription price

Avg: $67

EDWARD BATES MD

Internal Medicine

24,255

$1.11M

1012
801 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$46
Average prescription price

Avg: $67

RAVI SREERAMA M.D.

Internal Medicine

25,035

$1.07M

622
430 are 65+

N/A

29%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$43
Average prescription price

Avg: $67

MUHAMMAD NASIR MD

Internal Medicine

17,763

$1.04M

1119
590 are 65+

N/A

14%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $67

BLANCA GRAY MD

Internal Medicine

17,159

$1.03M

610
447 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

28%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $67

VALARIE ALLMAN M.D.

Internal Medicine

16,569

$957K

736
593 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $67

MANGALA RAMAMURTHY M.D.

Internal Medicine

14,940

$910K

544
396 are 65+

N/A

6%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

MIN GAO MD

Internal Medicine

14,267

$902K

747
507 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$63
Average prescription price

Avg: $67

MOGBOLAHAN KUYE MD

Internal Medicine

16,716

$891K

785
583 are 65+

N/A

17%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank